NCT00239278View on ClinicalTrials.gov

Budesonide / Formoterol in Treatment of Exacerbations of COPD

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

January 31, 2005

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

budesonide/formoterol, 2x 200/6 microgram. 4 times daily

DRUG

prednisolone, 30 mg once daily and placebo

Trial Locations (1)

Unknown

Research Site, Groningen

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY